SPI-62_DF2
SPI-62-CL-2001
Phase 2 small_molecule active
Quick answer
SPI-62_DF2 for Cushing's Syndrome is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Cushing's Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active